Clinical Trial Update: Analyzing the Pharmacodynamic Substances and the Effects of Xingnaojing for Mild-to-Severe Acute Ischemic Stroke [Phase 4]

View source ↗

Summary

Phase 4 trial update analyzing pharmacodynamic substances and effects of Xingnaojing in acute ischemic stroke.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Stroke

Drugs mentioned

• Xingnaojing

Snippet

Sponsor: Ying Gao | Conditions: Ischemic Stroke, Acute | Phase 4 | Status: UNKNOWN